A population-based study of the extent of surgical resection of potentially curable colon cancer
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
We attempted to determine factors contributing to the extent of initial curative resection for colon cancer in a population-based cohort. Total abdominal colectomy with ileorectal anastomosis (TAC-IR) may be considered for young patients or those with a colorectal cancer family history to prevent metachronous lesions and facilitate surveillance.
All Ontario patients newly diagnosed with colon cancer over 12 months beginning in July 1997 were staged at the time of surgery. The extent of resection was compared with variables, including familial risk obtained from the Ontario Familial Colon Cancer Registry.
Complete staging was possible for 86% of patients. A total of 1223 patients had a potentially curative resection: 17%, 46%, and 36% were stage I, II, and III, respectively. Patients were more likely to receive a TAC-IR if they were ≤50 years old (odds ratio [OR], 3.5; 95% confidence interval [CI], 1.8–6.6), if they had a synchronous lesion (OR, 28.37; 95% CI, 12.2–61.2), or if they were at a teaching hospital (OR, 2.8; 95% CI, 1.6–4.7), but not if they had a family history (OR, 7; 95% CI, 3–1.5).
Young age, teaching hospital, and multiple cancers but not family history were important factors for performing a TAC-IR.
- Terdiman JP, Conrad PG, Sleisenger MH. Genetic testing in hereditary colorectal cancer: indications and procedures.Am J Gastroenterol 1999;94:2344–56. CrossRef
- Burke W, Petersen GM, Lynch P, et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer, I. Hereditary nonpolyposis colon cancer.JAMA 1997;277: 915–9. CrossRef
- Mecklin JP, Jarvinen H. Treatment and follow-up strategies in hereditary nonpolyposis colorectal carcinoma.Dis Colon Rectum 1993;36:927–9. CrossRef
- Lynch HT, Lynch JF. Hereditary nonpolyposis colorectal cancer.Semin Surg Oncol 2000;18:305–13. CrossRef
- Guillem JG, Puig-La Calle J, Cellini C, et al. Varying features of early age-of-onset “sporadic” and hereditary nonpolyposis colorectal cancer patients.Dis Colon Rectum 1999;42:36–42. CrossRef
- Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Speizer FE, Willet WC. A prospective study of family history and the risk of colorectal cancer.N Engl J Med 1994;331:1669–74. CrossRef
- Ries LAG, Eisner MP, Kosary CL, et al, eds.SEER Cancer Statistics Review 1973–1997, Bethesda, MD: National Cancer Institute, 2000.
- Hall NR, Finan PJ, Ward B, Turner G, Bishop DT. Genetic susceptibility to colorectal cancer in patients under 45 years of age.Br J Surg 1994;81:1485–9. CrossRef
- Guillem JG, Bastar AL, Ng J, Huhn JL, Cohen AM. Clustering of colorectal cancer in families of probands under 40 years of age.Dis Colon Rectum 1996;39:1004–7. CrossRef
- Carstensen B, Soll-Johanning H, Villadsen E, Sondergaard JO, Lynge E. Familial aggregation of colorectal cancer in the general population.Int J Cancer 1996;68:428–35. CrossRef
- Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC).Dis Colon Rectum 1991;34:424–5. CrossRef
- Church JM. Prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer.Ann Med 1996;28:479–82.
- Syngal S, Fox EA, Li C, et al. Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: implications for clinical predisposition testing.JAMA 1999;282:247–53. CrossRef
- Genuardi M, Anti M, Capozzi E, et al. MLH1 and MSH2 constitutional mutations in colorectal cancer families not meeting the standard criteria for hereditary nonpolyposis colorectal cancer.Int J Cancer 1998;75:835–9. CrossRef
- Wijnen JT, Vasen HF, Khan PM, et al. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer.N Engl J Med 1998;339:511–8. CrossRef
- Beck NE, Tomlinson IP, Homfray T, Hodgson SV, Harocopos CJ, Bodmer WF. Genetic testing is important in families with a history suggestive of hereditary non-polyposis colorectal cancer even if the Amsterdam criteria are not fulfilled.Br J Surg 1997;84:233–7. CrossRef
- Madlensky L, Berk TC, Bapat BV, et al. A preventive registry for hereditary nonpolyposis colorectal cancer.Can J Oncol 1995;5: 355–60.
- Bapat BV, Madlensky L, Temple LK, et al. Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer.Hum Genet 1999; 104:167–76. CrossRef
- Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.Gastroenterology 1999;126:1453–6. CrossRef
- Haile RW, Siegmund KD, Gauderman WJ, Thomas DC. Studydesign issues in the development of the University of Southern California Consortium’s Colorectal Cancer Family Registry.J Natl Cancer Inst Monogr 1999;26:89–93.
- Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria teria for the determination of microsatellite instability in colorectal cancer.Cancer Res 1998;58:5248–57.
- Cali RL, Pitsch RM. Cumulative incidence of metachronous colorectal cancer.Dis Colon Rectum 1993;36:388–93. CrossRef
- Demeter JG, Freeark RJ. The role of prophylactic subtotal colectomy in metachronous carcinoma of the colon and rectum.Surg Gynecol Obstet 1992;175:1–7.
- Svendsen LB, Bulow S, Mellemgaard A. Metachronous colorectal cancer in young patients: expression of the hereditary nonpolyposis colorectal cancer syndrome?Dis Colon Rectum 1991;34:790–3. CrossRef
- Stern HS. Contributions of molecular genetics to the clinical management of colorectal cancer.Am J Surg 1996;171:10–5. CrossRef
- Brief DK, Brener BJ, Goldenkraz R, et al. Defining the role of subtotal colectomy in the treatment of carcinoma of the colon.Ann Surg 1991;213:248–52. CrossRef
- Berk T, Cohen Z. The inherited colorectal cancer registry: families are our patients. In: Schrock TR, ed.Perspectives in Colon and Rectal Cancer Surgery. 12th ed. New York: Thieme, 1999:1–12.
- Cotterchio M, McKeown-Eyssen G, Sutherland H, et al. Ontario Familial Colon Cancer Registry: methods and first-year response rates.Chronic Dis Can 2000;21:81–6.
- American Joint Committee on Cancer. Colon and rectum. In:AJCC Cancer Staging Manual. 5th ed. Philadelpha: Lippincott-Raven, 1997:95–8.
- Arbman G, Nilsson E, Storgren-Fordell V, Sjordahl R. Outcome of surgery for colorectal cancer in a defined population in Sweden from 1984 to 1986.Dis Colon Rectum 1995;38:645–50. CrossRef
- Aaltonen LA, Salovaara R, Kristo P, et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease.N Engl J Med 1998;338:1481–7. CrossRef
- Evans DG, Walsh S, Jeacock J, et al. Incidence of hereditary non-polyposis colorectal cancer in a population-based study of 1137 consecutive cases of colorectal cancer.Br J Surg 1997;84: 1281–5. CrossRef
- Salovaara R, Loukola A, Kristo P, et al. Population-based molecular detection of hereditary nonpolyposis colorectal cancer.J Clin Oncol 2000;18:2193–200.
- Rodriguez-Bigas MA, Vasen HF, Pekka-Mecklin J, et al. Rectal cancer risk in hereditary nonpolyposis colorectal cancer after abdominal colectomy.Ann Surg 1997;225:202–7. CrossRef
- McLaughlin J, Sloan M, Janovjak D.Cancer survival in Ontario. Toronto: Ontario Cancer Treatment and Research Foundation, 1995.
- Sutherland HJ, Lacroix J, Knight J, Andrulis IL, Boyd NF. The Cooperative Familial Registry for Breast Cancer Studies: design and first year recruitment rates in Ontario.J Clin Epidemiol 2001; 54:93–8. CrossRef
- King WD, Marrett LD, Woolcott CG. Case-control study of colon and rectal cancers and chlorination by-products in treated water.Cancer Epidemiol Biomarkers Prev 2000;9:813–8.
- Kampman E, Slattery ML, Bigler J, et al. Meat consumption, genetic susceptibility, and colon cancer risk: a United States multicenter case-control study.Cancer Epidemiol Biomarkers Prev 1999;8:15–24.
- Le Marchand L, Wilkens LR, Hankin JH, Kolonel LN, Lyu LC. Independent and joint effects of family history and lifestyle on colorectal cancer risk: implications for prevention.Cancer Epidemiol Biomarkers Prev 1999;8:45–51.
- Soravia C, Klein L, Berk T, O’Connor BI, Cohen Z, McLeod RS. Comparison of ileal pouch-anal anastomosis and ileorectal anastomosis in patients with familial adenomatous polyposis.Dis Colon Rectum 1999;42:1028–33. CrossRef
- Church JM, Fazio VW, Lavery IC, Oakley JR, Milsom J, McGannon E. Quality of life after prophylactic colectomy and ileorectal anastomosis in patients with familial adenomatous polysis.Dis Colon Rectum 1996;39:1404–8. CrossRef
- Gordon PH, Nivatvongs S, eds.Principles and Practice of Surgery for the Colon, Rectum, and Anus. 2nd ed. St Louis: Quality Medical Publishing, 1999.
- Single-stage treatment for malignant left-sided colonic obstruction: a prospective randomized clinical trial comparing subtotal colectomy with segmental resection following intraoperative irrigation. The SCOTIA Study Group. Subtotal colectomy versus on-table irrigation and anastomosis.Br J Surg 1995;82:1622–7.
- Eu KW, Lim SL, Seow-Choen F, Leong AF, Ho YH. Clinical outcome and bowel function following total abdominal colectomy and ileorectal anastomosis in the Oriental population.Dis Colon Rectum 1998;41:215–8. CrossRef
- Heriot AG, Murday V, Kumar D. Screening relatives of patients with colorectal cancer: the need for continuing education.J R Coll Surg Edinb 1999;44:13–5.
- Brueckl WM, Limmert T, Brabletz T. Mismatch repair deficiency in sporadic synchronous colorectal cancer.Anticancer Res 2000; 20:4727–32.
- A population-based study of the extent of surgical resection of potentially curable colon cancer
Annals of Surgical Oncology
Volume 9, Issue 4 , pp 380-387
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Colorectal neoplasms
- Family history
- Neoplasm staging
- Familial colorectal cancer
- Industry Sectors
- Author Affiliations
- 1. Room 3-130, Department of Surgical Oncology, Princess Margaret Hospital, 610 University Ave., M5G 2M9, Toronto, Ontario, Canada
- 2. Division of Preventive Oncology, Cancer Care Ontario, Toronto, Ontario, Canada
- 3. Department of Epidemiology & Statistics, Princess Margaret Hospital, Toronto, Ontario, Canada
- 4. Ontario Cancer Registry, Cancer Care Ontario, Toronto, Ontario, Canada
- 5. the Familial GI Cancer Registry, University of Toronto, Mount Sinai Hospital, Toronto, Ontario, Canada
- 6. Surveillance Unit, Cancer Care Ontario, Toronto, Ontario, Canada
- 7. Department of Surgery, University of Toronto, Mount Sinai Hospital, Toronto, Ontario, Canada